Postoperative prediction of disease-free survival in rectal cancer after neoadjuvant chemoradiotherapy and radical resection: a nomogram incorporating tumor regression grade and lymph node ratio
Abstract
PurposeTo develop and validate a nomogram incorporating tumor regression grade (TRG) and lymph node ratio (LNR) for predicting disease-free survival (DFS) after neoadjuvant chemoradiotherapy and radical resection for rectal cancer.MethodsThis retrospective study included 437 patients randomly divided into training (n = 305) and internal holdout validation (n = 132) cohorts, and 88 patients from an independent hospital for external validation. A nomogram estimating 3-year DFS was constructed using a multivariable Cox model. Performance was assessed using the concordance index (C-index), time-dependent area under the receiver operating characteristic curve (AUC), calibration, and decision curve analysis.ResultsMedian follow-up in the original cohort was 35.38 months. In the training and internal holdout cohorts, 106 patients (24.3%) experienced recurrence, distant metastasis, or death, as did 25 patients (28.4%) in the external validation cohort. In the multivariable model, poorer DFS was associated with TRG 2–3 (hazard ratio [HR], 2.45; 95% CI, 1.29–4.65), ypT3–4 (HR, 2.15; 95% CI, 1.12–4.15), ypN-positive disease (HR, 3.39; 95% CI, 1.73–6.63), and higher LNR (HR per 0.1 increase, 1.18; 95% CI, 1.06–1.32). The C-index was 0.830 (95% CI, 0.787–0.876) in training and 0.805 (95% CI, 0.726–0.887) in internal validation; the optimism-corrected C-index in the training cohort was 0.825. Compared with a reference model containing only ypT and ypN categories, the final model showed higher AUCs in the training cohort (0.841 vs. 0.792; AUC difference, 0.049; 95% CI, 0.025–0.088; P = 0.003), internal holdout validation cohort (0.789 vs. 0.735; AUC difference, 0.054; 95% CI, 0.005–0.108; P = 0.036), and external validation cohort (0.861 vs. 0.819; AUC difference, 0.042; 95% CI, 0.003–0.081; P = 0.034). After Holm adjustment, the P values for the AUC comparisons were 0.009, 0.068, and 0.068 in the training, internal holdout validation, and external validation cohorts, respectively. External calibration showed deviations in some probability ranges; decision curve analysis suggested potential net benefit.ConclusionsThe four-predictor postoperative nomogram showed promising discrimination for 3-year DFS, while its calibration, clinical utility, and generalizability require further evaluation in larger independent studies.
Related
- Prediction Models for Pathological Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis
- Identification of NUDT6 and LINGO1 as candidate genes for nCRT-associated signatures to neoadjuvant chemoradiotherapy in rectal cancer patients
- Short-Term Outcomes and Stoma-Related Morbidity of Diverting Ileostomy After Laparoscopic Total Mesorectal Excision Following Neoadjuvant Chemoradiotherapy for Mid- and Distal Rectal Cancer: A Retrospective Single-Center Study
- Neoadjuvant toripalimab plus concurrent chemoradiotherapy for locally advanced adenocarcinoma of the esophagogastric junction: a phase II trial
- Early postoperative prediction of gastrointestinal bleeding after surgery for acute type A aortic dissection: a five-variable logistic regression model benchmarked against machine learning.
BibTeX
@article{du2026postoperative,
title = {{Postoperative prediction of disease-free survival in rectal cancer after neoadjuvant chemoradiotherapy and radical resection: a nomogram incorporating tumor regression grade and lymph node ratio}},
author = {Zhaolin Du and Yunzhi Gao and Nan Zhang and Minghao Men and Xuefeng Zheng and Yinling Li and Wenchang Yang and Yuan Gao},
journal = {Frontiers in Oncology},
year = {2026},
month = nov,
doi = {10.3389/fonc.2026.1969622},
url = {https://www.frontiersin.org/articles/10.3389/fonc.2026.1969622},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Postoperative prediction of disease-free survival in rectal cancer after neoadjuvant chemoradiotherapy and radical resection: a nomogram incorporating tumor regression grade and lymph node ratio
AU - Zhaolin Du
AU - Yunzhi Gao
AU - Nan Zhang
AU - Minghao Men
AU - Xuefeng Zheng
AU - Yinling Li
AU - Wenchang Yang
AU - Yuan Gao
PY - 2026
DA - 2026/11/11
JO - Frontiers in Oncology
DO - 10.3389/fonc.2026.1969622
UR - https://www.frontiersin.org/articles/10.3389/fonc.2026.1969622
AB - PurposeTo develop and validate a nomogram incorporating tumor regression grade (TRG) and lymph node ratio (LNR) for predicting disease-free survival (DFS) after neoadjuvant chemoradiotherapy and radical resection for rectal cancer.MethodsThis retrospective study included 437 patients randomly divided into training (n = 305) and internal holdout validation (n = 132) cohorts, and 88 patients from an independent hospital for external validation. A nomogram estimating 3-year DFS was constructed using a multivariable Cox model. Performance was assessed using the concordance index (C-index), time-dependent area under the receiver operating characteristic curve (AUC), calibration, and decision curve analysis.ResultsMedian follow-up in the original cohort was 35.38 months. In the training and internal holdout cohorts, 106 patients (24.3%) experienced recurrence, distant metastasis, or death, as did 25 patients (28.4%) in the external validation cohort. In the multivariable model, poorer DFS was associated with TRG 2–3 (hazard ratio [HR], 2.45; 95% CI, 1.29–4.65), ypT3–4 (HR, 2.15; 95% CI, 1.12–4.15), ypN-positive disease (HR, 3.39; 95% CI, 1.73–6.63), and higher LNR (HR per 0.1 increase, 1.18; 95% CI, 1.06–1.32). The C-index was 0.830 (95% CI, 0.787–0.876) in training and 0.805 (95% CI, 0.726–0.887) in internal validation; the optimism-corrected C-index in the training cohort was 0.825. Compared with a reference model containing only ypT and ypN categories, the final model showed higher AUCs in the training cohort (0.841 vs. 0.792; AUC difference, 0.049; 95% CI, 0.025–0.088; P = 0.003), internal holdout validation cohort (0.789 vs. 0.735; AUC difference, 0.054; 95% CI, 0.005–0.108; P = 0.036), and external validation cohort (0.861 vs. 0.819; AUC difference, 0.042; 95% CI, 0.003–0.081; P = 0.034). After Holm adjustment, the P values for the AUC comparisons were 0.009, 0.068, and 0.068 in the training, internal holdout validation, and external validation cohorts, respectively. External calibration showed deviations in some probability ranges; decision curve analysis suggested potential net benefit.ConclusionsThe four-predictor postoperative nomogram showed promising discrimination for 3-year DFS, while its calibration, clinical utility, and generalizability require further evaluation in larger independent studies.
SN - 2234-943X
ER -